Bristol Myers Squibb Presents Analyses from Pivotal QUAZAR® AML-001 Study of Onureg® in Adults with Acute Myeloid Leukemia in First Remission Biotech Investing
Trillium Therapeutics Presented Clinical Data at the 62nd ASH Annual Meeting and Provides Guidance for 2021 Biotech Investing
Bristol Myers Squibb Presents Data Evaluating Potential of Liso-cel Across Leukemia and Lymphomas at ASH 2020 Biotech Investing
Amgen And Novartis Partner With Karamo Brown To Support And Empower People Living With Migraine Biotech Investing
Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead's Antiviral Remdesivir Utilizing Matinas' LNC Platform Delivery Technology Biotech Investing
Lexaria to Highlight its DehydraTECH Technology at Four Upcoming Investor Conferences Biotech Investing
Yescarta® Shows Positive Results as a First-Line Treatment for Patients With High-Risk Large B-cell Lymphoma Biotech Investing
Combined Data from Multiple Phase 3 Studies of IMBRUVICA® Show Efficacy and Safety in High-Risk, Previously Untreated Chronic Lymphocytic Leukemia and Real-World Data Indicating Low Biomarker Testing Rates for These Patients Biotech Investing
Magrolimab Demonstrates Clinical Responses in Ongoing Phase 1b Trial of Previously Untreated Acute Myeloid Leukemia Patients Biotech Investing
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTE® Therapy AMG 701 At ASH 2020 Biotech Investing
